RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: dermatomyositis
Accession: DOID:10223
browse the term
Definition: A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)
Synonyms: exact_synonym: Dermatopolymyositides; Dermatopolymyositis; Polymyositis-Dermatomyositides; dermatomyositides; polymyositis dermatomyositis; polymyositis with skin involvement
related_synonym: Amyopathic dermatomyositis
primary_id: MESH:D003882
xref: GARD:6263 ; ICD10CM:M33 ; ICD10CM:M33.9 ; ICD10CM:M33.90 ; ICD9CM:710.3 ; NCI:C26744 ; ORDO:221
For additional species annotation, visit the
Alliance of Genome Resources .
G
Angptl2
angiopoietin-like 2
ISS
MouseDO
NCBI chr 3:16,517,185...16,547,024
Ensembl chr 3:16,517,420...16,548,178
G
C2
complement C2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3501473
NCBI chr20:3,951,474...3,970,376
Ensembl chr20:3,951,474...3,976,505
G
C9
complement C9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11359403
NCBI chr 2:55,573,094...55,621,345
Ensembl chr 2:55,572,992...55,621,338
G
Ccr2
C-C motif chemokine receptor 2
ISO
protein:increased expression:limb muscle:
RGD
PMID:15772970
RGD:8661727
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Cd36
CD36 molecule
ISO
mRNA:increased expression:skeletal muscle
RGD
PMID:17572512
RGD:6893508
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd40
CD40 molecule
ISO
RGD
PMID:18050371
RGD:8547765
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd40lg
CD40 ligand
ISO
RGD
PMID:18050371
RGD:8547765
NCBI chr X:135,127,119...135,138,302
Ensembl chr X:135,126,969...135,138,306
G
Cx3cl1
C-X3-C motif chemokine ligand 1
ISO
protein:expression:serum
RGD
PMID:22394569
RGD:9491763
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Fas
Fas cell surface death receptor
ISO
protein:increased expression:serum (human)
RGD
PMID:9182923
RGD:8662437
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Hgf
hepatocyte growth factor
disease_progression
ISO
protein:increased expression:serum:
RGD
PMID:8952317
RGD:8548628
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Ifng
interferon gamma
ISO
mRNA:increased expression:skeletal muscle
RGD
PMID:19953283
RGD:7794747
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il18
interleukin 18
ISO
protein:increased expression:serum
RGD
PMID:20601655
RGD:4889547
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19035492
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19035492
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il4
interleukin 4
ISO
mRNA:increased expression:skeletal muscle
RGD
PMID:19953283
RGD:7794747
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Mbl2
mannose binding lectin 2
susceptibility
ISO
DNA:polymorphisms:cds:p.G54D,G57E(human)
RGD
PMID:12485445
RGD:8693750
NCBI chr 1:228,016,439...228,024,736
G
Mmp1
matrix metallopeptidase 1
ISO
mRNA:increased expression:skeletal muscle
RGD
PMID:11157561
RGD:8547876
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp9
matrix metallopeptidase 9
ISO
mRNA:increased expression:skeletal muscle
RGD
PMID:11157561
RGD:8547876
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Pms1
PMS1 homolog 1, mismatch repair system component
ISO
RGD
PMID:15856462
RGD:2324870
NCBI chr 9:48,229,403...48,340,237
Ensembl chr 9:48,253,410...48,340,237
G
RT1-A1
RT1 class Ia, locus A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3501473
NCBI chr20:4,905,309...4,914,593
G
Stat4
signal transducer and activator of transcription 4
ISO
DNA:SNP: :rs7574865 (human)
RGD
PMID:22402141
RGD:8661693
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
G
Thbd
thrombomodulin
ISO
RGD
PMID:17899683
RGD:5685006
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Tlr2
toll-like receptor 2
ISO
mRNA,protein:increased expression:muscle
RGD
PMID:19953283
RGD:7794747
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
ISO
mRNA,protein:increased expression:muscle
RGD
PMID:19953283
RGD:7794747
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tlr9
toll-like receptor 9
ISO
mRNA,protein:increased expression:muscle
RGD
PMID:19953283
RGD:7794747
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19035492
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
RT1-Ba
RT1 class II, locus Ba
susceptibility
ISO
DNA:polymorphism (human) DNA:polymorphism: :HLA-DQA1*0501;
RGD
PMID:18671865 PMID:15067086 PMID:8666549
RGD:5147790 , RGD:5147796 , RGD:8547569
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
C3
complement C3
ISO
associated with Leprosy
RGD
PMID:2783924
RGD:7421527
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Cfb
complement factor B
ISO
associated with Leprosy
RGD
PMID:2783924
RGD:7421527
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
G
Gstm1
glutathione S-transferase mu 1
susceptibility
ISO
associated with Behcet Syndrome;DNA:deletion:: (human)
RGD
PMID:22766250
RGD:7794848
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Lta
lymphotoxin alpha
ISO
associated with Sarcoidosis;DNA:polymorphism:intron
RGD
PMID:19225544
RGD:8548773
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
G
RT1-A1
RT1 class Ia, locus A1
ISO
associated with Inflammatory Bowel Diseases; DNA:polymorphisms:cds:multiple (human)
RGD
PMID:12198697
RGD:7364926
NCBI chr20:4,905,309...4,914,593
G
RT1-CE13
RT1 class I, locus CE13
ISO
associated with Inflammatory Bowel Diseases; DNA:polymorphisms:cds:multiple (human)
RGD
PMID:12198697
RGD:7364926
NCBI chr20:3,314,984...3,318,037
G
Tnf
tumor necrosis factor
susceptibility
ISO
associated with Inflammatory Bowel Diseases;DNA:polymorphisms: :-1031T>C(human)
RGD
PMID:12198697
RGD:7364926
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Vdr
vitamin D receptor
susceptibility
ISO
associated with Behcet Syndrome;DNA:polymorphism: : rs7975232(human)
RGD
PMID:24880677
RGD:13217417
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Serpina1
serpin family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3259592 PMID:6982619
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
G
Otulin
OTU deubiquitinase with linear linkage specificity
ISO
ClinVar Annotator: match by term: Autoinflammation, panniculitis, and dermatosis syndrome
OMIM ClinVar
PMID:25741868 PMID:27523608 PMID:27559085 PMID:28492532
NCBI chr 2:78,290,437...78,316,633
Ensembl chr 2:78,290,959...78,316,422
G
Havcr2
hepatitis A virus cellular receptor 2
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Subcutaneous panniculitis-like T-cell lymphoma
CTD OMIM ClinVar
PMID:25741868 PMID:30374066 PMID:30792187
NCBI chr10:30,882,484...30,914,018
Ensembl chr10:30,882,606...30,909,137
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all